FDA.reportPublic FDA data

cabozantinib 20 MG Oral Tablet

RxCUI
1790161
RxNorm name
cabozantinib 20 MG Oral Tablet
Display name
cabozantinib 20 MG Oral Tablet
Full name
cabozantinib 20 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CABOMETYXCABOZANTINIBExelixis, Inc.3850cce2-6137-42e5-a792-d318c4a4b3b52025-10-19Warnings, Adverse reactionsExact identifier
rxcui: 1790161

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3850cce2-6137-42e5-a792-d318c4a4b3b5cabozantinib 20 MG Oral Tablet [PSN] · cabozantinib 20 MG Oral Tablet [SCD] · cabozantinib 20 MG (as cabozantinib (S)-malate 25 MG) Oral Tablet [SY]318These highlights do not include all the information needed to use CABOMETYX safely and effectively. See full prescribing information for CABOMETYX. CABOMETYX ® (cabozantinib) tablets, for oral use Initial U.S. Approval: 201220251019